Intuitive Surgical, Inc. (ISRG)
| Market Cap | 142.23B -8.5% |
| Revenue (ttm) | 11.03B +20.7% |
| Net Income | 3.14B +20.4% |
| EPS | 8.72 +21.6% |
| Shares Out | 353.28M |
| PE Ratio | 46.06 |
| Forward PE | 35.55 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 529,521 |
| Open | 403.00 |
| Previous Close | 401.65 |
| Day's Range | 397.72 - 403.97 |
| 52-Week Range | 328.57 - 603.88 |
| Beta | 1.46 |
| Analysts | Buy |
| Price Target | 476.34 (+18.31%) |
| Earnings Date | Oct 20, 2026 |
About ISRG
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling,... [Read more]
Financial Performance
In 2025, Intuitive Surgical's revenue was $10.06 billion, an increase of 20.51% compared to the previous year's $8.35 billion. Earnings were $2.86 billion, an increase of 22.97%.
Financial StatementsAnalyst Summary
According to 32 analysts, the average rating for ISRG stock is "Buy." The 12-month stock price target is $476.34, which is an increase of 18.31% from the latest price.
News
Intuitive Surgical Transcript: Wells Fargo 21st Annual Healthcare Conference
Global procedure growth remains a priority, with innovation and new programs like Extended Use Instruments aimed at stimulating growth, especially in cost-sensitive markets. Capital equipment placements are strong, competition is intensifying, and AI-driven digital offerings are gaining traction. Financial performance is robust, exceeding long-term averages.
New meta-analysis shows statistically significant improvements in patient outcomes associated with da Vinci surgery versus laparoscopic and open surgery across 13 common benign conditions
Largest comparative meta-analysis of its kind found da Vinci robotic-assisted surgery was associated with shorter hospital stays and a faster return to work compared with laparoscopic and open surgery...
Intuitive Collaborates with Deion “Coach Prime” Sanders to Raise Patient Awareness of Surgical Options
Intuitive today announced a collaboration with Deion “Coach Prime” Sanders to help increase patient awareness and understanding of surgical options.
Intuitive Shares Vision for an AI-Enabled Future of Healthcare
SUNNYVALE, Calif., July 23, 2026 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, will outline its visio...
Why Intuitive Surgical Stock Plunged Today
Intuitive Surgical (ISRG) shares plummeted Friday after the maker of robotic surgical tools failed to raise the outlook for its flagship product despite better-than-expected second-quarter results.
Friday's Morning Movers: SPCX Scrubs Test Flights, AAPL Upgrade, ISRG Earnings
Diane King Hall discusses Intuitive Surgical (ISRG) earnings, explaining how GLP-1 trends have hit the company. She also talks about SpaceX (SPCX) shares coming back to Earth after scrubbing Starship'...
Intuitive Surgical falls as Obamacare concerns rekindle medtech demand debate
Intuitive Surgical shares fell more than 12% before the bell on Friday after it maintained its global growth forecast for procedures performed with its da Vinci surgical robots and warned that change...
Intuitive Surgical stock sinks despite earnings beat on 2026 procedure growth outlook
Shares of Intuitive Surgical tumbled about 12% in premarket trading on Friday after the robotic surgery company issued a full-year procedure growth outlook that fell short of investor expectations, ov...
Intuitive Surgical beats quarterly estimates on strong demand for its robotic systems
Intuitive Surgical on Thursday maintained its 2026 forecast for worldwide growth in procedures assisted by its cutting-edge da Vinci robots, after beating Wall Street estimates for second-quarter pr...
Intuitive Surgical Earnings Call Transcript: Q2 2026
Q2 delivered strong revenue and procedure growth, driven by robust adoption of da Vinci 5, SP, and Ion platforms. Guidance for 2026 remains positive, with continued innovation, stable capital demand, and expanding access in cost-sensitive markets.
Intuitive Surgical Earnings release: Q2 2026
Intuitive Surgical released its Q2 2026 earnings on July 16, 2026, summarizing the period's financial results.
Intuitive Surgical Slides: Q2 2026
Intuitive Surgical has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 16, 2026.
Intuitive Surgical Quarterly report: Q2 2026
Intuitive Surgical has published its Q2 2026 quarterly earnings report on July 16, 2026.
Intuitive Announces Second Quarter Earnings
SUNNYVALE, Calif., July 16, 2026 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today ...
Intuitive Announces New Chief Commercial and Marketing Officer Taylor Patton
Current Chief Commercial and Marketing Officer Henry Charlton to become SVP of Global Business Operations Current Chief Commercial and Marketing Officer Henry Charlton to become SVP of Global Business...
Intuitive Announces Innovations to Advance Quintuple Aim
Latest innovations include enhanced telecollaboration capabilities, extended uses for Force Feedback technology, and advancements in product and instrument reliability and security Latest innovations ...
AI, Obesity Drugs, and Diagnostics Fuel Healthcare Growth
Healthcare is regaining momentum as innovation—especially AI‑driven drug discovery—creates new growth opportunities, according to Shivani Vohra. She points to obesity treatments from Eli Lilly (LLY) a...
Intuitive Surgical Transcript: AGM 2026
The meeting saw all board nominees elected and all proposals approved, including executive compensation and auditor ratification. Strong financial results were reported for 2025 and Q1 2026, with continued focus on global expansion, innovation, and manufacturing optimization amid competitive and geopolitical challenges.
The Biggest Takeaway From ISRG Earnings
The key takeaway from Intuitive Surgical's (ISRG) Q1 2026 results is the implementation of a fundamental “Platform Refresh Wall.” In addition to the $2.50 EPS exceeding expectations and a revenue grow...
Intuitive Surgical beats quarterly expectations on surgical robot demand
Intuitive Surgical on Tuesday beat Wall Street estimates for first-quarter profit and revenue, as the firm rode the wave of robust demand for its minimally invasive surgical robots used in complex m...
Intuitive Announces First Quarter Earnings
SUNNYVALE, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today...
Intuitive Surgical Earnings Call Transcript: Q1 2026
Q1 2026 delivered strong 17% procedure growth and 23% revenue growth, led by robust adoption of da Vinci 5, Ion, and SP platforms, with notable expansion in the U.S. and Europe. Guidance for full-year procedure growth and gross margin was raised, while ongoing challenges persist in China and Japan.
Intuitive Surgical Earnings release: Q1 2026
Intuitive Surgical released its Q1 2026 earnings on April 21, 2026, summarizing the period's financial results.
Intuitive Surgical Quarterly report: Q1 2026
Intuitive Surgical has published its Q1 2026 quarterly earnings report on April 21, 2026.
Intuitive Surgical Slides: Q1 2026
Intuitive Surgical has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 21, 2026.